Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study

MLA

Margaret Tonda, et al. “Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study.” Blood, vol. 134, Nov. 2019, p. 2313. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........bbe8a3fe91c155c0f47fee4016102dad&authtype=sso&custid=ns315887.

APA

Margaret Tonda, Joshua Lehrer-Graiwer, Adlette Inati, Irene Agodoa, Kenneth I. Ataga, Elliott Vichinsky, Paul Telfer, & Barbara Tong. (2019). Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study. Blood, 134, 2313.

Chicago

Margaret Tonda, Joshua Lehrer-Graiwer, Adlette Inati, Irene Agodoa, Kenneth I. Ataga, Elliott Vichinsky, Paul Telfer, and Barbara Tong. 2019. “Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study.” Blood 134 (November): 2313. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........bbe8a3fe91c155c0f47fee4016102dad&authtype=sso&custid=ns315887.